I 2 PP2A regulates p53 and Akt correlatively and leads the neurons to abort apoptosis

Neurobiology of Aging

Volumn 33, Issue 2, 2012, Pages 254-264

  Liu, Gong Ping ^a   Wei, Wei ^a   Zhou, Xin ^a   Zhang, Yao ^a   Shi, Hai Hong ^a   Yin, Jun ^a   Yao, Xiu Qing ^a   Peng, Cai Xia ^a   Hu, Juan ^a   Wang, Qun ^a   Li, Hong Lian ^a   Wang, Jian Zhi ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Akt; Alzheimer disease; Apoptosis; P53; Protein phosphatase 2A inhibitor 2

Indexed keywords

CASPASE 3; CYCLIN DEPENDENT KINASE 5; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN KINASE B; PROTEIN P53;

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; BRAIN CORTEX; BRAIN REGION; CELL LOSS; CELL VIABILITY; CONTROLLED STUDY; HIPPOCAMPUS; HUMAN; HUMAN CELL; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; UPREGULATION;

ANIMALS; APOPTOSIS; GENE EXPRESSION REGULATION; HEK293 CELLS; HISTONE CHAPERONES; HUMANS; MICE; MICE, TRANSGENIC; NEURONS; PROTO-ONCOGENE PROTEINS C-AKT; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 82755163086     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2010.01.016     Document Type: Article

References (41)

1. Al-Murrani S.W., Woodgett J.R., Damuni Z. Expression of I2PP2A, an inhibitor of protein phosphatase 2A, induces c-Jun and AP-1 activity. Biochem. J. 1999, 341:293-298.
2. Andjelković M., Jakubowicz T., Cron P., Ming X.F., Han J.W., Hemmings B.A. Activation and phosphorylation of a pleckstrin homology domain containing protein kinase (RAC-PK/PKB) promoted by serum and protein phosphatase inhibitors. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:5699-5704.
3. Braak E., Braak H., Mandelkow E.M. A sequence of cytoskeleton changes related to the formation of neurofibrillary tangles and neuropil threads. Acta Neuropathol. 1994, 87:554-567.
4. Brazil D.P., Yang Z.Z., Hemmings B.A. Advances in protein kinase B signalling: AKTion on multiple fronts. Trends Biochem. Sci. 2004, 29:233-242.
5. Brummelkamp T.R., Bernards R., Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science 2002, 296:550-553.
6. Bulavin D.V., Demidov O.N., Saito S., Kauraniemi P., Phillips C., Amundson S.A., Ambrosino C., Sauter G., Nebreda A.R., Anderson C.W., Kallioniemi A., Fornace A.J., Appella E. Amplification of PPM1D in human tumors abrogates p53 tumor-suppressor activity. Nat. Genet. 2002, 31:210-215.
7. Canela N., Rodriguez-Vilarrupla A., Estanyol J.M., Diaz C., Pujol M.J., Agell N., Bachs O. The SET protein regulates G2/M transition by modulating cyclin B-cyclin-dependent kinase 1 activity. J. Biol. Chem. 2003, 278:1158-1164.
8. Compagnone N.A., Zhang P., Vigne J.L., Mellon S.H. Novel role for the nuclear phosphoprotein SET in transcriptional activation of P450c17 and initiation of neurosteroidogenesis. Mol. Endocrinol. 2000, 14:875-888.
9. Chohan M.O., Khatoon S., Iqbal I.G., Iqbal K. Involvement of I2PP2A in the abnormal hyperphosphorylation of tau and its reversal by Memantine. FEBS Lett. 2006, 580:3973-3979.
10. Darzynkiewicz Z., Juan G., Li X., Gorczyca W., Murakami T., Traganos F. Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry 1997, 27:1-20.
11. Dey R., Majumder N., Bhattacharjee S., Majumdar S.B., Banerjee R., Ganguly S., Das P., Majumdar S. Leishmania donovani-induced ceramide as the key mediator of Akt dephosphorylation in murine macrophages: role of protein kinase Czeta and phosphatase. Infect. Immun. 2007, 75:2136-2142.
12. Dickson D.W. Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect?. J. Clin. Invest. 2004, 114:23-27.
13. Dull T., Zufferey R., Kelly M., Mandel R.J., Nguyen M., Trono D., Naldini L. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 1998, 72:8463-8471.
14. Elbashir S.M., Harborth J., Lendeckel W., Yalcin A., Weber K., Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001, 411:494-498.
15. Franke T.F., Kaplan D.R., Cantley L.C. PI3K: downstream AKTion blocks apoptosis. Cell 1997, 88:435-437.
16. Gamble M.J., Erdjument-Bromage H., Tempst P., Freedman L.P., Fisher R.P. The histone chaperone TAF-I/SET/INHAT is required for transcription in vitro of chromatin templates. Mol. Cell. Biol. 2005, 25:797-807.
17. Ishiguro K., Shiratsuchi A., Sato S., Omori A., Arioka M., Kobayashi S., Uchida T., Imahori K. Glycogen synthase kinase 3 beta is identical to tau protein kinase I generating several epitopes of paired helical filaments. FEBS Lett. 1993, 325:167-172.
18. Jellinger K.A. Cell death mechanisms in neurodegeneration. J. Cell Mol. Med. 2001, 5:1-17.
19. Kaspar B.K., Vissel B., Bengoechea T., Crone S., Randolph-Moore L., Muller R., Brandon E.P., Schaffer D., Verma I.M., Lee K.F., Heinemann S.F., Gage F.H. Adeno-associated virus effectively mediates conditional gene modification in the brain. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:2320-2325.
20. Kim Y.S., Carp R.I., Callahan S.M., Wisniewski H.M. Incubation periods and survival times for mice injected stereotaxically with three scrapie strains in different brain regions. J. Gen. Virol. 1987, 68:695-702.
21. Kitamura Y., Shimohama S., Kamoshima W., Matsuoka Y., Nomura Y., Taniguchi T. Changes of p53 in the brains of patients with Alzheimer's disease. Biochem. Biophys. Res. Commun. 1997, 232:418-421.
22. Ksiezak-Reding H., Pyo H.K., Feinstein B., Pasinetti G.M. Akt/PKB kinase phosphorylates separately Thr212 and Ser214 of tau protein in vitro. Biochim. Biophys. Acta. 2003, 1639:159-168.
23. Lee J.H., Kim H.S., Lee S.J., Kim K.T. Stabilization and activation of p53 induced by Cdk-5 contributes to neuronal cell death. J. Cell Sci. 2007, 120:2259-2271.
24. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell 1997, 88:323-331.
25. Li H.L., Wang H.H., Liu S.J., Deng Y.Q., Zhang Y.J., Tian Q., Wang X.C., Chen X.Q., Yang Y., Zhang J.Y., Wang Q., Xu H., Liao F.F., Wang J.Z. Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a mechanism involved in Alzheimer's neurodegeneration. Proc. Natl. Acad. Sci. U.S.A. 2007, 104:3591-3596.
26. Li M., Guo H., Damuni Z. Purification and characterization of two potent heat-stable protein inhibitors of protein phosphatase 2A from bovine kidney. Biochemistry 1995, 34(6):1988-1996.
27. Liu G.P., Zhang Y., Yao X.Q., Zhang C.E., Fang J., Wang Q., Wang J.Z. Activation of glycogen synthase kinase-3 inhibits protein phosphatase-2A and the underlying mechanisms. Neurobiol. Aging 2008, 29:1348-1358.
28. Liu W., Akhand A.A., Takeda K., Kawamoto Y., Itoigawa M., Kato M., Suzuki H., Ishikawa N., Nakashima I. Protein phosphatase 2A-linked and -unlinked caspase-dependent pathways for downregulation of Akt kinase triggered by 4-hydroxynonenal. Cell Death Differ. 2003, 10:772-781.
29. Marr R.A., Rockenstein E., Mukherjee A., Kindy M.S., Hersh L.B., Gage F.H., Verma I.M., Masliah E. Neprilysin gene transfer reduces human amyloid pathology in transgenic mice. J. Neurosci. 2003, 23:1992-1996.
30. Oda K., Arakawa H., Tanaka T., Matsuda K., Tanikawa C., Mori T., Nakamura Y., Taya Y. p53AIP1, a potential mediator of p53-dependent apoptosis, and its regulation by Ser-46-phosphorylated p53. Cell 2000, 102:849-862.
31. Raina A.K., Hochman A., Ickes H., Zhu X., Ogawa O., Cash A.D., Shimohama S., Perry G., Smith M.A. Apoptotic promoters and inhibitors in Alzheimer's disease: who wins out?. Prog. Neuropsychopharmacol. Biol. Psychiatry 2003, 27:251-254.
32. Selkoe D.J. The deposition of amyloid proteins in the aging mammalian brain: implications for Alzheimer's disease. Ann. Med. 1989, 21:73-76.
33. Shin K.S., Shin E.Y., Bae S.C., Kim S.R., Jeong G.B., Kwak S.J., Ballermann B.J., Kim E.G. Expression of SET is modulated as a function of cell proliferation. J. Cell Biochem. 1999, 74:119-126.
34. Tanimukai H., Grundke-Iqbal I., Iqbal K. Up-regulation of inhibitors of protein phosphatase-2A in Alzheimer's disease. Am. J. Pathol. 2005, 166:1761-1771.
35. ten Klooster J.P., Leeuwen I., Scheres N., Anthony E.C., Hordijk P.L. Rac1-induced cell migration requires membrane recruitment of the nuclear oncogene SET. EMBO J. 2007, 26:336-345.
36. Wang J.Z., Gong C.X., Zaidi T., Grundke-Iqbal I., Iqbal K. Dephosphorylation of Alzheimer paired helical filaments by protein phosphatase-2A and -2B. J. Biol. Chem. 1995, 270(9):4854-4860.
37. Wang J.Z., Grundke-Iqbal I., Iqbal K. Restoration of biological activity of Alzheimer abnormally phosphorylated tau by dephosphorylation with protein phosphatase-2A, -2B and -1. Brain Res. Mol. Brain Res. 1996, 38(2):200-208.
38. Wang J.Z., Grundke-Iqbal I., Iqbal K. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration. Eur. J. Neurosci. 2007, 25:59-68.
39. Wang J.Z., Liu F. Microtubule-associated protein tau in development, degeneration and protection of neurons. Prog. Neurobiol. 2008, 85:148-175.
40. Yuan J., Yankner B.A. Apoptosis in the nervous system. Nature 2000, 407:802-809.
41. Zhang C.E., Wei W., Liu Y.H., Peng J.H., Tian Q., Liu G.P., Zhang Y., Wang J.Z. Hyperhomocysteinemia increases beta-amyloid by enhancing expression of gamma-secretase and phosphorylation of amyloid precursor protein in rat brain. Am. J. Pathol. 2009, 174(4):1481-1491.